↑ トップへ ← 戻る

 Drug(薬物リスト) DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

31 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Acei   -   -   -   -   2件:
66,
224 
 2   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 3   Angiotensin   Angiotensin ii   D00150, D02014   2件: AGTR1, AGTR2   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   7件:
17,
19,
46,
66,
86,
222,
224 
 4   Angiotensin-converting enzyme (ace) inhibitor   Angiotensin ii   D00150, D02014   2件: AGTR1, AGTR2   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
224 
 5   Angiotensin-converting enzyme inhibitor(acei)   Angiotensin ii   D00150, D02014   2件: AGTR1, AGTR2   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
224 
 6   Benazepril   Benazepril   D00620, D07499   1件: ACE   4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   3件:
57,
218,
224 
 7   Benazepril hydrochloride tablets   Benazepril   D00620, D07499   1件: ACE   4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   1件:
224 
 8   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 9   Chinese herbs based on syndrome differentiation   -   -   -   -   1件:
224 
 10   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 11   Cyclophosphamide(ctx)   Cyclophosphamide   D00287, D07760   -   -   1件:
224 
 12   Dipyridamole   Dipyridamole   D00302   2件: PDE4A, PDE5A   6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway   5件:
46,
49,
51,
66,
224 
 13   Dipyridamole tab 25 mg   Dipyridamole   D00302   2件: PDE4A, PDE5A   6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
224 
 14   Glycosides of tripterygium wilfordii hook(gtw)   Tripterygium wilfordii whole   -   -   -   1件:
224 
 15   Heparin   Heparin   D07510   1件: SERPINC1   1件: Complement and coagulation cascades   11件:
60,
70,
79,
84,
107,
224,
226,
280,
299,
316,
317 
 16   Leflunomide   Leflunomide   D00749   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   9件:
11,
40,
46,
49,
53,
66,
224,
271,
300 
 17   Leflunomide(lef)   Leflunomide   D00749   1件: DHODH   2件: Metabolic pathways, Pyrimidine metabolism   1件:
224 
 18   Low molecular weight heparin calcium injection   Calcium, Heparin   D07510   1件: SERPINC1   1件: Complement and coagulation cascades   1件:
224 
 19   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 20   Mizoribine   Mizoribine   D01392   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   7件:
49,
51,
53,
66,
94,
222,
224 
 21   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 22   Mycophenolate mofetil   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 23   Mycophenolate mofetil(mmf)   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   1件:
224 
 24   Prednisone   Prednisone   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 25   Prednisone acetate   Prednisone acetate   D08416   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   3件:
40,
49,
224 
 26   Prednisone acetate tablets   Prednisone acetate   D08416   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
224 
 27   Qi-ji shen-kang formula   -   -   -   -   1件:
224 
 28   Sulfotanshinone sodium injection   -   -   -   -   1件:
224 
 29   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 30   Tripterygium   Tripterygium wilfordii whole   -   -   -   8件:
46,
66,
67,
96,
162,
222,
224,
271 
 31   Tripterygium wilfordii   Tripterygium wilfordii whole   -   -   -   6件:
46,
66,
67,
222,
224,
271 

先頭へ